New research related to H3K27M-mutant diffuse midline glioma with extensive intratumoral microthrombi in young adults with COVID-19 from the Department of Pathology was just published in Acta Neurologica. [...]
A new study from the Andrew Lieberman Laboratory’s Samir Nath, et al, has discovered that MEF2 impairment underlies skeletal muscle atrophy in polyglutamine disease.
Kennedy’s Disease, also known as Spinal and Bulbar Muscular Atrophy (SBMA), is a disease caused by an inherited gene mutation that results in muscle and brain cell dysfunction. Patients progressively lose muscle mass until they are unable to walk without assistance. Ultimately [...]
Chan Chung, PhD, received two grants in funding from the ChadTough Foundation and Defeat DIPG foundation ($150,000) and the Robert Connor Dawes CERN Pediatric Fellowship ($100,000). [...]
In September of 2019, Sean Ferris, MD, PhD, moved his family from San Francisco to Ann Arbor to join the Department of Pathology as an assistant professor specializing in neuropathology in the division of anatomic pathology. [...]
Andrew Lieberman, MD, PhD, Gerald D. Abrams Collegiate Professor and Director of Neuropathology, has been elected to serve on the Neuropathology Core Steering Committee of the National Alzheimer’s Coordinating Center (NACC). The goal of the [...]
Assistant Professor Sriram Venneti, M.D., Ph.D. is one of 17 recipients of the Doris Duke Charitable Foundation’s 19th Clinical Scientist Development Awards. The awards are designed to allow junior faculty protected time for their clinical research as they establish their own research programs.
Assistant Professor, Sriram Venneti, MD, PhD, was named a Kimmel Scholar by the Sidney Kimmel Foundation. The Kimmel Scholar Awards are given annually to 15 innovative research scientists and medical doctors in the U.S. who are in the early stages of their careers. Dr. Venneti will receive a $200,000 grant for his work, titled, “Metabolic regulation of epigenetics in childhood brain tumors.” Congratulations, Dr. Venneti, on being recognized as one of the country’s most promising young cancer researchers!
The 2nd Annual Protein Folding Diseases Initiative Symposium, “Molecules and Machines”, was held on Friday, September 18, 2015, at the A. Alfred Taubman Biomedical Science Research Building.
The University of Michigan Protein Folding Diseases Initiative (PFDI), lead by Drs. Andrew Lieberman and Henry Paulson, seeks to connect the diverse campus-wide expertise on disorders of abnormal protein accumulation and perturbations in “protein quality control.”